Medication Affordability and Patent Integrity Act
USA118th CongressHR-5429| House
| Updated: 9/15/2023
Ann M. Kuster
Democratic Representative
New Hampshire
Cosponsors (1)
Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Commerce
Drug safety, medical device, and laboratory regulationInflation and pricesIntellectual propertyManufacturingPrescription drugs
Medication Affordability and Patent Integrity Act
USA118th CongressHR-5429| House
| Updated: 9/15/2023
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Ann M. Kuster
Democratic Representative
New Hampshire